Unicycive Therapeutics (UNCY) Short term Debt (2020 - 2024)
Unicycive Therapeutics (UNCY) recorded Short term Debt of $208,000 in Q1 2024.
Powered by 
Analysis
Unicycive Therapeutics (UNCY) Short term Debt (2020 - 2024) Analysis & Trends
At the end of FY2020, Unicycive Therapeutics reported Short term Debt of $967,000.
- The Q1 2024 figure is the highest quarterly Short term Debt since Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Unicycive Therapeutics | 101.95 Mn | -98.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 208,000.00 |
| Sep 30, 2021 | 103,000.00 |
| Jun 30, 2021 | 901,000.00 |
| Dec 31, 2020 | 967,000.00 |
API Access
Unicycive Therapeutics Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=UNCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "UNCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=UNCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();